140 related articles for article (PubMed ID: 15467710)
1. Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer.
Friedrichs N; Jäger R; Paggen E; Rudlowski C; Merkelbach-Bruse S; Schorle H; Buettner R
Mod Pathol; 2005 Mar; 18(3):431-8. PubMed ID: 15467710
[TBL] [Abstract][Full Text] [Related]
2. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
Gee JM; Eloranta JJ; Ibbitt JC; Robertson JF; Ellis IO; Williams T; Nicholson RI; Hurst HC
J Pathol; 2009 Jan; 217(1):32-41. PubMed ID: 18825690
[TBL] [Abstract][Full Text] [Related]
4. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
[TBL] [Abstract][Full Text] [Related]
5. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
[TBL] [Abstract][Full Text] [Related]
6. Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
Jäger R; Friedrichs N; Heim I; Büttner R; Schorle H
Breast Cancer Res Treat; 2005 Apr; 90(3):273-80. PubMed ID: 15830141
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of AP-2gamma and AP-2alpha during human trophoblast differentiation.
Richardson BD; Cheng YH; Langland RA; Handwerger S
Life Sci; 2001 Sep; 69(18):2157-65. PubMed ID: 11669459
[TBL] [Abstract][Full Text] [Related]
8. AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.
Li H; Watts GS; Oshiro MM; Futscher BW; Domann FE
Oncogene; 2006 Aug; 25(39):5405-15. PubMed ID: 16636674
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Livasy CA; Karaca G; Nanda R; Tretiakova MS; Olopade OI; Moore DT; Perou CM
Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
11. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors.
Allouche A; Nolens G; Tancredi A; Delacroix L; Mardaga J; Fridman V; Winkler R; Boniver J; Delvenne P; Begon DY
Breast Cancer Res; 2008; 10(1):R9. PubMed ID: 18218085
[TBL] [Abstract][Full Text] [Related]
12. Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.
Powe DG; Akhtar G; Habashy HO; Abdel-Fatah T; Rakha EA; Green AR; Ellis IO
Breast Cancer Res; 2009; 11(6):R90. PubMed ID: 20025767
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.
Putti TC; El-Rehim DM; Rakha EA; Paish CE; Lee AH; Pinder SE; Ellis IO
Mod Pathol; 2005 Jan; 18(1):26-35. PubMed ID: 15332092
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
15. Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.
Pellikainen JM; Kosma VM
Int J Cancer; 2007 May; 120(10):2061-7. PubMed ID: 17330235
[TBL] [Abstract][Full Text] [Related]
16. A
Wu VT; Kiriazov B; Koch KE; Gu VW; Beck AC; Borcherding N; Li T; Addo P; Wehrspan ZJ; Zhang W; Braun TA; Brown BJ; Band V; Band H; Kulak MV; Weigel RJ
Mol Cancer Res; 2020 Jan; 18(1):46-56. PubMed ID: 31619506
[TBL] [Abstract][Full Text] [Related]
17. Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells.
Ailan H; Xiangwen X; Daolong R; Lu G; Xiaofeng D; Xi Q; Xingwang H; Rushi L; Jian Z; Shuanglin X
BMC Cancer; 2009 Aug; 9():279. PubMed ID: 19671168
[TBL] [Abstract][Full Text] [Related]
18. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.
Man YG; Tai L; Barner R; Vang R; Saenger JS; Shekitka KM; Bratthauer GL; Wheeler DT; Liang CY; Vinh TN; Strauss BL
Breast Cancer Res; 2003; 5(6):R231-41. PubMed ID: 14580259
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M
Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth.
Zhu CH; Domann FE
Breast Cancer Res Treat; 2002 Jan; 71(1):47-57. PubMed ID: 11859873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
